Infliximab therapeutic drug monitoring ( DrugBank: Infliximab )
2 diseases
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 96 | クローン病 | 1 |
| 97 | 潰瘍性大腸炎 | 1 |
96. クローン病
臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04775732 (ClinicalTrials.gov) | June 1, 2018 | 25/2/2021 | Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease | Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point-of-care-testing in Inflammatory Bowel Disease: a Pragmatic Trial | Crohn Disease;Ulcerative Colitis | Biological: infliximab therapeutic drug monitoring | Imelda GI Clinical Research Center | NULL | Completed | N/A | N/A | All | 187 | Phase 4 | Belgium |
97. 潰瘍性大腸炎
臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04775732 (ClinicalTrials.gov) | June 1, 2018 | 25/2/2021 | Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease | Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point-of-care-testing in Inflammatory Bowel Disease: a Pragmatic Trial | Crohn Disease;Ulcerative Colitis | Biological: infliximab therapeutic drug monitoring | Imelda GI Clinical Research Center | NULL | Completed | N/A | N/A | All | 187 | Phase 4 | Belgium |